PALB2 and breast cancer: According to the results of genetic testing, 35 patients (excluding the three patients carrying multiple different gene mutations) carrying one germline mutation in an FA gene (except BRCA1/2, PALB2 and RAD51C) were included in the mutation group, and 1,133 patients who did not carry any mutations in BC susceptibility genes were the control group.